HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell Culture

This publication has 39 references indexed in Scilit:

• Inhibition of Cholesterol Synthesis by Squalene Synthase Inhibitors Does Not Induce Myotoxicityin Vitro
  Toxicology and Applied Pharmacology, 1997
• Specific Labeling of Isoprenylated Proteins: Application to Study Inhibitors of the Post-translational Farnesylation and Geranylgeranylation
  Biochemical and Biophysical Research Communications, 1995
• Rhabdomyolysis and Acute Renal Failure in a Heart Transplant Recipient Treated with Hypolipemiants
  Nephron, 1994
• Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells
  Journal of Cellular Physiology, 1993
• Simvastatin-induced rhabdomyolysis followed by a melas syndrome
  The American Journal of Medicine, 1993
• Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
  Molecular and Cellular Biology, 1992
• Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine.
  BMJ, 1992
• Lovastatin/Gemfibrozil Myopathy: A Clinical, Histochemical, and Ultrastructural Study
  European Neurology, 1992
• Quantitation of prenylcysteines by a selective cleavage reaction.
  Proceedings of the National Academy of Sciences, 1991
• Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac Transplantation
  New England Journal of Medicine, 1988